Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
MaxCyte, Inc. MXCT.L
$305.00
-$7.32 (-2.40%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
391593800.00000000
-
week52high
650.00
-
week52low
280.00
-
Revenue
44261500
-
P/E TTM
-2510
-
Beta
0.70305300
-
EPS
-0.18000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BTIG | Buy | Buy | 15 авг 2022 г. |
| William Blair | Outperform | 24 авг 2021 г. | |
| Stifel | Buy | 24 авг 2021 г. | |
| Stephens & Co. | Overweight | 24 авг 2021 г. | |
| Cowen & Co. | Outperform | 24 авг 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии